Literature DB >> 23355208

Expansion of a clonal CD8+CD57+ large granular lymphocyte population after autologous stem cell transplant in multiple myeloma.

Kristy L Wolniak1, Charles L Goolsby, Y-Hua Chen, Anjen Chenn, Seema Singhal, Lo Ann C Peterson.   

Abstract

Clonal expansions of large granular lymphocytes (LGLs) have been identified in patients following stem cell transplants and may represent posttransplant LGL leukemias or reactive immune responses. To differentiate between these 2 possibilities, we assessed peripheral blood and bone marrow of patients with myeloma after autologous stem cell transplant. All patients examined shortly after autologous stem cell transplant had significant increases in the LGLs in the peripheral blood and bone marrow (71% of lymphocytes) as compared with controls (39%). This increase was detectable years after transplant. The LGLs had a reproducible immunophenotype of CD8+CD57+ T cells without phenotypic abnormalities in 19 of 20 patients. Sixty-five percent of the post-autologous stem cell transplant patients had clonal T-cell receptor gene rearrangements in the bone marrow, yet no patients had neutropenia or splenomegaly. Although the LGL expansions were clonal and persistent, the lack of clinical sequelae suggests the clonal LGL expansion is a reactive, potentially beneficial, immune response to autologous stem cell transplant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355208     DOI: 10.1309/AJCP1T0JPBLSLAQF

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Phosphorylated STAT3 expression in hematopoietic stem cell transplant-associated large granular lymphocytic leukemia.

Authors:  C S Liang; A E Quesada; M Goswami; P K Johnston; R E Brown; J M Jaso
Journal:  Bone Marrow Transplant       Date:  2016-01-11       Impact factor: 5.483

2.  T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics.

Authors:  Min Shi; Horatiu Olteanu; Dragan Jevremovic; Rong He; David Viswanatha; Heidi Corley; Pedro Horna
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

3.  Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro.

Authors:  Isabelle Krämer; Melanie Engelhardt; Sabrina Fichtner; Brigitte Neuber; Sergej Medenhoff; Uta Bertsch; Jens Hillengass; Marc-Steffen Raab; Dirk Hose; Anthony D Ho; Hartmut Goldschmidt; Michael Hundemer
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

Review 4.  Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.

Authors:  Camille Guillerey; Kyohei Nakamura; Slavica Vuckovic; Geoffrey R Hill; Mark J Smyth
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

Review 5.  Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.

Authors:  Kazuo Oshimi
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

6.  T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes.

Authors:  Ming Liang Oon; Jing Quan Lim; Bernett Lee; Sai Mun Leong; Gwyneth Shook-Ting Soon; Zi Wei Wong; Evelyn Huizi Lim; Zhenhua Li; Allen Eng Juh Yeoh; Shangying Chen; Kenneth Hon Kim Ban; Tae-Hoon Chung; Soo-Yong Tan; Shih-Sung Chuang; Seiichi Kato; Shigeo Nakamura; Emiko Takahashi; Yong-Howe Ho; Joseph D Khoury; Rex K H Au-Yeung; Chee-Leong Cheng; Soon-Thye Lim; Wee-Joo Chng; Claudio Tripodo; Olaf Rotzschke; Choon Kiat Ong; Siok-Bian Ng
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

Review 7.  Large granular lymphocytosis after transplantation.

Authors:  Zhi-Yuan Qiu; Guang-Yu Tian; Zhao Zhang; Ye-Qing Zhang; Wei Xu; Jian-Yong Li
Journal:  Oncotarget       Date:  2017-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.